Both in Pharmaceuticals
Filana Therapeutics vs TransCode Therapeutics
Over the past year FLNA returned −27.3% and RNAZ returned −8.0%; their daily moves had a correlation of 0.09.
FLNA −27.3% RNAZ −8.0%Growth of $1, one year, split-adjusted
| Metric | FLNA | RNAZ |
|---|---|---|
| Price | $0.5614 | $1.56 |
| Market cap | $27.1M | $26.3M |
| Today | +0.07% | −4.60% |
| 1 month | −35.5% | −11.6% |
| 6 months | — | −80.2% |
| Year to date | — | −77.2% |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $82.7M | $7.7M |
| Dividend yield | — | — |
| Volatility (60d) | — | 75.8% |
| Short % of float | 12.2% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).